[18f]fluoropivalate ([18f]fluoro-2,2-dimethylpropionic acid)
Small moleculeexperimentalImaging agent
Clinical trial activity
1 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Aug 31, 2021 (NCT04717674)
Timeline
2020s
- Jan 1, 2021
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Unspecified targetRadiopharmaceutical
radiopharmaceutical
Chemistry & pharmacology
- Imaging
- 18-fluorine
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04717674 | Phase 2 | Aug 31, 2021 | Cancer Research UK, Government of United Kingdom, Imperial College London, University of London |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Cancer Research UK | Academic/Hospital | 1 | 0 | 1 | 2021 |
| Government of United Kingdom | Government | 1 | 0 | 1 | 2021 |
| Imperial College London | Academic/Hospital | 1 | 0 | 1 | 2021 |
| University of London | Academic/Hospital | 1 | 1 | 1 | 2021 |
4 organizations
Page 1 / 1